Sees 2023 adjusted EBITDA $10.0M-$12.0M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HCAT:
- Health Catalyst Reports Third Quarter 2023 Preliminary Results
- Health Catalyst to Announce Third Quarter 2023 Operating Results and Host Conference Call on Wednesday, November 8, 2023
- Health Catalyst price target lowered to $15 from $20 at BTIG
- Health Catalyst price target lowered to $10 from $14 at Evercore ISI
- Health Catalyst management to meet with BTIG